Integrative Health Grand Rounds: "Psychedelic Medicines in Palliative Care," Brian T. Anderson, MD
Psychedelic Medicines in Palliative Care
Presented by Brian T. Anderson, MD, MSc
Brian T. Anderson, MD, MSc, is a psychiatrist at Zuckerberg San Francisco General Hospital, and an Assistant Clinical Professor in the UCSF Department of Psychiatry and Behavioral Sciences. He is a founding investigator at the UC Berkeley Center for the Science of Psychedelics and he is affiliated with UCSF Neuroscape. His research group takes a public health approach to conducting clinical trials and observational studies that seek to improve how we address suffering and despair among people living with serious medical illness and people who use drugs. For over 15 years Dr. Anderson has studied the medical and non-medical uses of controlled substances, with a focus on psychedelics used in therapeutic and religious settings.
Learning Objectives:
At the conclusion of the program, learners will be more able to:
- Differentiate the demoralization syndrome from clinical depression.
- Describe the current science and regulatory status of psychedelic medicines for patients with serious medical illness.
- Evaluate designs for studying if psilocybin could improve cancer survival.
Continuing Education:
This UCSF continuing education activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
UCSF adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including content planners, reviewers, authors, presenters, moderators, panelists, or others are required to disclose all financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.
Accreditation:
In support of improving patient care, the University of California, San Francisco Office of Continuing Medical Education (CME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This CME activity meets the requirements under California Assembly 1195, continuing education, and cultural and linguistic competency.
UCSF designates this live activity for a maximum of 10 AMA PRA Category 1 credit(s)TM.
Attendees should claim only the credit commensurate with the extent of their participation in the activity. The credit maximum above reflects all Osher Center for Integrative Health Grand Rounds sessions in Fiscal Year 2027. Up to 1 credit may be claimed against any individual session. In order to receive credit you must certify your attendance in this session and claim your credits earned in the activity within 6 days of its conclusion.
California Acupuncturists: This live activity is approved by the State of California Acupuncture Board for 1 hour of Category 1 CE course credit. (provider number 1377).
Conflict of Interest Disclosure Statement:
Planners: The planners Shelley Adler, PhD, Selena Chan, DO, and Patty Moran, PhD, have no relationships to disclose.
Speaker: Brian Anderson, MD, has no financial relationships to disclose.